# Zenas BioPharma, Inc. (ZBIO) FY2026 Q2 Balance Sheet

- Company: Zenas BioPharma, Inc. (ZBIO)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-13, accession number 0001104659-26-095448
- Page: https://plicit.ai/financials/zbio/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/zbio-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 701,690,000 US dollars
- **Current assets**: 653,794,000 US dollars
- **Non-current assets**: 47,896,000 US dollars
- **Liabilities**: 454,593,000 US dollars
- **Current liabilities**: 65,818,000 US dollars
- **Non-current liabilities**: 388,775,000 US dollars
- **Equity**: 247,097,000 US dollars
- **Short-term investments**: 446,549,000 US dollars
- **Cash and cash equivalents**: 196,577,000 US dollars
- **Prepaid expenses and other current assets**: 10,668,000 US dollars
- **Long-term investments**: 30,763,000 US dollars
- **Other non-current assets**: 16,289,000 US dollars
- **Operating lease right-of-use assets, net**: 821,000 US dollars
- **Property and equipment, net**: 23,000 US dollars
- **Accrued expenses**: 57,406,000 US dollars
- **Accounts payable**: 7,589,000 US dollars
- **Operating lease liabilities, current**: 823,000 US dollars
- **Convertible senior notes, net**: 222,956,000 US dollars
- **Royalty obligation**: 91,737,000 US dollars
- **Senior secured term loan, net**: 74,060,000 US dollars
- **Operating lease liabilities, less current portion**: 22,000 US dollars
- **Additional paid-in capital**: 1,205,803,000 US dollars
- **Common stock, par value $0.0001 per share; 175,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 63,330,747 and 54,485,518 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 6,000 US dollars
- **Accumulated deficit**: negative 957,571,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,141,000 US dollars
- **Gross equity (calculated)**: 1,205,809,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.